Evidence map›Paper›PMID 42910404›Full record

ArticleNanotheranostics2026

Longitudinal, Non-invasive Live Near-Infrared Fluorescence Imaging of Acute Vascularized Composite Allograft Rejection Validated by

Jelena M Janjic, Yalcin Kulahci, Fatih Zor, Sanjida Ahmed Srishti, Riddhi Vichare, Lesley M Foley, Zeynep Demir, Bedreddin Sazoğlu, Fatma Nurefsan Selek, Omer Dirican and 8 more

Abstract read
In one paragraph

Article in Nanotheranostics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Jelena M JanjicNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Yalcin KulahciWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Fatih ZorWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Sanjida Ahmed SrishtiNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Riddhi VichareNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Lesley M FoleyAdvanced Imaging Center, University of Pittsburgh, Pittsburgh, PA, USA.
Zeynep DemirWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Bedreddin SazoğluWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Fatma Nurefsan SelekWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Omer DiricanWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
Vidya SurtiNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Stefan StratimirovicNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Caitlin CrelliNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Rebecca McCallinNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Michele HerneiseyNanomedicine Manufacturing Laboratory, Graduate School of Pharmaceutical Sciences and School of Pharmacy, Duquesne University, Pittsburgh, PA, USA.
Huseyin KaragozWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.
T Kevin HitchensAdvanced Imaging Center, University of Pittsburgh, Pittsburgh, PA, USA.
Vijay S GorantlaWake Forest Institute for Regenerative Medicine, Advocate Health - Atrium Wake Forest Baptist Medical Center, Winston-Salem, NC, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute rejection remains a major cause of graft attrition in vascularized composite allotransplantation (VCA). Clinical assessment and superficial biopsy may fail to detect early or spatially heterogeneous inflammatory infiltration, particularly within deeper graft compartments. Because macrophages are among the earliest mediators of alloimmune activation, they represent an attractive target for noninvasive immune surveillance of skin-bearing grafts. We evaluated longitudinal near-infrared fluorescence (NIRF) imaging of macrophage infiltration using a perfluoro-15-crown-5 ether nanoemulsion (PCE-NE) labeled with a near-infrared fluorophore in a rat hindlimb transplantation model and a radial forearm flap model in non-human primates (NHPs). Single- and dual-dose administration strategies enabled serial visualization of macrophage recruitment and improved detection of evolving inflammatory responses during acute rejection. To capture the spatial heterogeneity of rejection, a multi-sampled region-of-interest analysis framework was developed for quantitative mapping of NIRF signal across donor and recipient tissues in rats and throughout transplanted flap regions in NHPs. To validate

Indexed as

Composite Tissue AllograftsFluorine-19 Magnetic Resonance ImagingGraft RejectionOptical ImagingVascularized Composite AllotransplantationAnimalsCrown EthersFluorocarbonsHindlimbMacrophagesMaleRatsCrown EthersFluorocarbonsperfluoro-15-crown-5-etheracute rejectioncell trackingfluorine-19 magnetic resonance imagingnear-infrared fluorescence imagingvascularized composite allotransplantation

Identifiers

PMID42910404
PMCPMC13686790

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.